| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.341 | 2.169 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 2.341 | 2.169 | 0 | 0 | 0 | 0 | 0 | 33.089 | 0 | 0 |
| Total Expenses - EUR | 2.015 | 4.319 | 146 | 321 | 1.770 | 254 | 571 | 13.595 | 315 | 439 |
| Gross Profit/Loss - EUR | 326 | -2.150 | -146 | -321 | -1.770 | -254 | -571 | 19.494 | -315 | -439 |
| Net Profit/Loss - EUR | 256 | -2.215 | -146 | -321 | -1.770 | -254 | -571 | 18.501 | -315 | -439 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - New Biosolaris Sistem Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 22.163 | 17.250 | 16.359 | 16.151 | 14.255 | 13.987 | 13.428 | 169 | 586 | 560 |
| Inventories | 6.276 | 2.036 | 2.001 | 1.965 | 311 | 306 | 299 | 0 | 0 | 0 |
| Receivables | 15.812 | 15.221 | 14.360 | 14.146 | 13.901 | 13.640 | 13.089 | 128 | 142 | 160 |
| Cash | 0 | 0 | 0 | 40 | 42 | 41 | 40 | 40 | 445 | 399 |
| Shareholders Funds | -18.734 | -20.758 | -20.552 | -20.497 | -21.870 | -21.709 | -21.799 | -3.365 | -3.669 | -4.088 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 40.897 | 38.008 | 36.912 | 36.647 | 36.125 | 35.696 | 35.227 | 3.533 | 4.255 | 4.648 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "113 - 113" | |||||||||
| CAEN Financial Year |
113
|
|||||||||
Comments - New Biosolaris Sistem Srl